Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-21,378
Closed -$2.12M 538
2019
Q3
$2.12M Buy
21,378
+9,173
+75% +$872K 0.4% 135
2019
Q2
$1.13M Sell
12,205
-3,986
-25% -$379K 0.22% 186
2019
Q1
$1.53M Sell
16,191
-17,796
-52% -$1.56M 0.31% 168
2018
Q4
$2.18M Buy
33,987
+6,575
+24% +$485K 0.51% 23
2018
Q3
$2.45M Buy
27,412
+11
+0% +$972 0.55% 31
2018
Q2
$2.18M Buy
27,401
+8,153
+42% +$677K 0.51% 34
2018
Q1
$1.72M Buy
+19,248
New +$1.85M 0.41% 35

Other funds holding CELG

Fort LP's CELG Position: Q4 2019 in Review

Fort LP sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 21,378 shares — an estimated $2.12M sold.

Fort LP first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $2.45M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Fort LP reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Fort LP sold 21,378 Celgene Corp shares in Q4 2019, an estimated $2.12M.
  • Fort LP first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Fort LP's Celgene Corp position peaked at $2.45M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Fort LP's 13F filing for Q4 2019, filed 13 Feb 2020.